In addition, we suggest here that NFATc3 is a key positive regulator of RCAN1-4, COX-2; TNF-α; CXCR-3, GM-CSF and IL-2, known to be implicated in glioma growth15–21. The gene discussed is CSF2; the disease is central nervous system cancer.